ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
8 announcements
Qualitek Labs Limited held its 8th Annual General Meeting on September 25, 2026. Shareholders approved financial statements, re-appointment of the MD, and material related party transactions.
Qualitek Labs Ltd issued an EGM notice to seek shareholder approval for a preferential issuance of 3.86 lakh equity shares and 5.20 lakh convertible warrants.
Qualitek Labs replaced one proposed allottee in its preferential issue. The number of shares for this allocation remains unchanged at 16,000.
Qualitek Labs will issue 3.86 lakh equity shares and 5.20 lakh fully convertible warrants on a preferential basis to raise capital for the company.
Qualitek Labs has scheduled a Board Meeting for September 22, 2026, to consider a fund raising proposal. No specific amount or terms are disclosed yet.
Qualitek Labs Limited has withdrawn Item No. 4 (regarding increased managerial remuneration) from its upcoming Annual General Meeting notice. Other AGM businesses remain unchanged.
Qualitek Labs delivered strong FY26 results with consolidated revenue of ₹124.5 Cr, a four-fold increase over FY24, driven by acquisitions and segment diversification.
Qualitek Labs Ltd reported revenue from operations of ₹70.3 Cr and net profit of ₹9.8 Cr for H2 FY26.